Enter your address for a quick guide on ways to get involved, and to receive our monthly newsletter.
Enter your address for a quick guide on ways to get involved, and to receive our monthly newsletter.
As a passionate
community,
we're urgently working together.
Fueled by our coast-to-coast grassroots community, we’re proud to be the country’s only nonprofit that exclusively funds metastatic breast cancer research through a peer-and-patient-advocate review process. Learn how we’re advancing research, improving federal policy through advocacy, and facilitating a community of peer-to-peer support.
Explore ongoing trials, get information and participate in surveys offered by our industry partners.
The OPERA-02 study will enroll adults who have locally advanced, non-curable breast cancer that has spread to other parts of the body. The goal is to see if a new, experimental drug called palazestrant is safe and effective when taken with standard breast cancer medicines.
To join, your cancer must be ER-positive (meaning it uses the hormone estrogen to grow) and HER2-negative. You must also have not yet received treatment for your advanced cancer.
Sponsorships from these pharmaceutical and biotech organizations help fund our operations, allowing our volunteer-led nonprofit to dedicate 90% of all donations directly to MBC research while connecting our community to opportunities of interest.
Upcoming
events & news
Find out what’s happening in the METAvivor community and join us at an event.